Product Image

Natural Soy Lecithin Granules

4.8
★ ★ ★ ★ ★
(941 ratings)
Potassium 100 mg
Product Image
Score70
Simple soy lecithin granules with unquantified phospholipids and only trace mineral support. They fit general food use better than a focused heart regimen.
How scoring works
Powder
Quantity:12 Ounce(s) • (45 servings)
Goals:
Heart Health

Score 70

Simple soy lecithin granules with unquantified phospholipids and only trace mineral support. They fit general food use better than a focused heart regimen.
How scoring works
$18.23($0.40 per serving)
iHerb
$ 18.23
Vitacost
$ 20.07
Pure Formulas
$ 18.23
Report prices

Analysis

Soy lecithin is a source of phospholipids that can be incorporated easily into foods and drinks. The label does not state phosphatidylcholine or other individual phospholipid amounts, so active composition remains uncertain.

Potassium and magnesium contribute only small amounts and are not identified by mineral form. The granules contain no cholesterol or sodium, but that basic nutrition profile does not make them a targeted heart supplement.

The product best fits people who specifically want soy lecithin as a food ingredient. Anyone seeking meaningful potassium, magnesium, or broad cardiovascular support should look elsewhere.

Who is it for
  • People who want soy lecithin granules
  • Users who prefer food-mix formats
  • Adults interested in dietary phospholipids
Best for
  • Mixing lecithin into foods or drinks
  • General phospholipid intake
  • Users avoiding capsules

Pros

  • Simple soy lecithin format
  • Contains no listed sodium or cholesterol
  • Easy to mix into meals

Cons

  • Individual phospholipids are not quantified
  • Potassium and magnesium amounts are small
  • Mineral forms are not disclosed

Warnings

  • Soy lecithin is unsuitable for people with a soy allergy.
  • The granules add dietary fat and calories that may matter when portions are increased beyond the labeled serving.

Nutrient quality

74 High impact

Soy lecithin is a coherent phospholipid source, but its individual active fractions are not quantified. Mineral amounts are small, while the simple granules remain conservatively dosed and focused.

Ingredient transparency

64 Moderate impact

Basic nutrition amounts are stated, but the lecithin amount and individual phospholipid composition are absent. Complete directions and processing details are also incomplete.

Customer satisfaction

71 High impact

The exceptional average rating and substantial review count make the aggregate satisfaction signal reasonably dependable. No detailed review text was provided, so recurring complaints and purpose alignment cannot be assessed.

Value for money

71 High impact

A simple food-based format and modest serving cost provide fair value. Missing lecithin and phospholipid quantities weaken comparison with better-specified products.

Report analysis

Goals

Heart Health
Healthy Blood Pressure
Heart Health
Impact
Moderate effect
D+ Goal FitF Strength of SupportD- CoverageB+ Formula Quality
Magnesium · 14 mgVitamin D · mcg

Soy lecithin supplies phospholipids that may contribute to normal lipid transport, but the heart-specific active content is not quantified. The simple granules avoid stimulants and proprietary botanical blends.

Phosphatidylcholine and other individual phospholipids are not disclosed, while potassium and magnesium are nutritionally trivial. The evidence and dose information are too limited for confident cardiovascular use.

Study evidence
Magnesium Supportive 158 studies
Potassium Supportive 182 studies

Ingredients

IngredientAmount per serving
Calories
40 Calorie(s)
Total Fat
4 Gram(s)
Cholesterol
0 mg
Sodium
0 mg
Total Carbohydrate
1 Gram(s)
Protein
0 Gram(s)
Vitamin D
0 mcg
Calcium
10 mg
Iron
0.17 mg
Potassium
100 mg
Magnesium
14 mg
Gluten Free Adults 18–50
Report overview
Potassium · 100 mg OverallScore36
F Active Ingredient Quality & BioavailabilityD Dose, Safety & Label TransparencyD+ Value
Soy lecithin granules provide only a small potassium contribution and do not identify its chemical form. The nutrition-style panel gives a usable elemental amount without source-compound detail. Low serving cost partly offsets the limited dose.
View ingredientView products
Loading alternative details
87 Performance

Potassium Bicarbonate 1.3 g

Nutricost
<p>A clearly labeled 494 mg of potassium bicarbonate provides a meaningful, alkalizing alternative to the original's potassium contribution. The simple powder improves dose clarity, but impaired kidney function or potassium-retaining medicines can make the amount unsafe without guidance. It does not replace the original's other active ingredients or broader intended use.</p>
83 Performance

Potassium Citrate

NOW
<p>Potassium citrate supplies a meaningful 448 mg amount in a well-absorbed, alkalizing form. Its focused label gives stronger form and dose clarity than many mixed products, while kidney impairment and potassium-retaining medicines can raise blood potassium too far. It does not replace the original's other active ingredients or broader intended use.</p>
80 Performance

Albion Complexed Potassium 99 mg

Swanson Ultra
<p>A named Albion amino acid complex provides a clearly identified potassium form for users who prefer a low-dose capsule. The 99 mg amount is far smaller than the higher-dose powder options, so its advantage is form clarity rather than substantial electrolyte delivery. It does not replace the original's other active ingredients or broader intended use.</p>
85 Budget

Potassium Chloride 365 mg

Nutricost
<p>A clearly quantified 365 mg of potassium chloride makes this a focused, low-cost substitute for the original's potassium component. Chloride supports electrolyte replacement but lacks the buffering role of citrate or bicarbonate, and kidney impairment or potassium-retaining medicines can make supplementation unsafe. It does not replace the original's other active ingredients or broader intended use.</p>
81 Budget

Potassium Chloride Powder

NOW
<p>The simple powder provides 365 mg of potassium as chloride with very low recurring cost. It is easier to assess than a broad blend but lacks citrate's buffering role, while kidney impairment or potassium-retaining medicines remain important cautions. It does not replace the original's other active ingredients or broader intended use.</p>
80 Budget

Potassium 99 mg

Thompson
<p>A 99 mg potassium amino acid complex offers a low-cost, deliberately modest alternative to the original. The amount contributes little beside daily dietary needs, so it fits limited supplementation rather than substantial electrolyte replacement. It does not replace the original's other active ingredients or broader intended use.</p>
81 Value

Potassium (Citrate)

Pure Encapsulations
<p>A simple capsule supplies 200 mg of potassium citrate, providing an absorbable and alkalizing form at a moderate amount. It offers a practical middle ground between low-dose tablets and concentrated powders, with the same kidney and medication cautions that apply to added potassium. It does not replace the original's other active ingredients or broader intended use.</p>
80 Value

Potassium Gluconate Pure Powder

NOW
<p>A focused powder supplies 175 mg of potassium gluconate with excellent recurring value. The amount is more useful than a basic 99 mg tablet but remains a limited contribution beside dietary needs, and potassium retention from kidney disease or medicines still matters. It does not replace the original's other active ingredients or broader intended use.</p>
78 Value

Potassium 99 mg

Country Life
<p>Citrate and an amino acid chelate provide useful form quality in a streamlined supplement. Repeated 99 mg entries make the total potassium amount ambiguous, but the low recurring cost supports cautious, modest use. It does not replace the original's other active ingredients or broader intended use.</p>
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Potassium intake, stroke, and cardiovascular disease a meta-analysis of prospective studies.
    D'Elia L; Barba G; Cappuccio FP; Strazzullo P · Journal of the American College of Cardiology · 2011
    Meta-analysis247,510 participants11 studies pooledHeart Health forPotassium
  2. Oral potassium supplementation for management of essential hypertension: A meta-analysis of randomized controlled trials.
    Poorolajal J; Zeraati F; Soltanian AR; Sheikh V; Hooshmand E; Maleki A · PloS one · 2017
    Meta-analysis1,213 participants23 studies pooledHeart Health forPotassium
  3. Effect of Potassium Supplementation on Endothelial Function: A Systematic Review and Meta-Analysis of Intervention Studies.
    D'Elia L; Cappuccio FP; Masulli M; La Fata E; Rendina D; Galletti F · Nutrients · 2023
    Meta-analysis332 participants5 studies pooledHeart Health forPotassium
  4. Magnesium and Potassium Supplementation for Systolic Blood Pressure Reduction in the General Normotensive Population: A Systematic Review and Subgroup Meta-Analysis for Optimal Dosage and Treatment Length.
    Behers BJ; Behers BM; Stephenson-Moe CA; Vargas IA; Meng Z; Thompson AJ; Melchor J; Wojtas CN; Rosario MA; Baker JF; Deevers AC; Mouratidis RW; Sweeney MJ · Nutrients · 2024
    Meta-analysisHeart Health forPotassium
  5. Potassium intake and risk of stroke in women with hypertension and nonhypertension in the Women's Health Initiative.
    Seth A; Mossavar-Rahmani Y; Kamensky V; Silver B; Lakshminarayan K; Prentice R; Van Horn L; Wassertheil-Smoller S · Stroke · 2015
    Cohort study90,137 participantsHeart Health forPotassium
  6. Effect of high potassium diet on endothelial function.
    Blanch N; Clifton PM; Petersen KS; Willoughby SR; Keogh JB · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2015
    Randomized trial35 participantsHeart Health forPotassium
  7. Associations between sodium, potassium, and blood pressure: results from the Hispanic Community Health Study/Study of Latinos, a prospective cohort study.
    Swift SL; Sotres-Alvarez D; Raij L; Wassertheil-Smoller S; Schneiderman N; Llabre M; Zeki Al Hazzouri A; Rundek T; Van Horn L; Daviglus M; Castaneda S; Youngblood M; Mossavar-Rahmani Y; Elfassy T · The American journal of clinical nutrition · 2024
    Cohort study11,429 participantsHeart Health forPotassium
  8. Serum potassium levels provide prognostic information in symptomatic heart failure beyond traditional clinical variables.
    Toledo CC; Vellosa Schwartzmann P; Miguel Silva L; da Silva Ferreira G; Bianchini Cardoso F; Citelli Ribeiro V; Paim LR; Antunes-Correa LM; Carvalho Sposito A; Matos Souza JR; Modolo R; Nadruz W; Fernandes de Carvalho LS; Coelho-Filho OR · ESC heart failure · 2021
    Cohort study178 participantsHeart Health forPotassium
  9. Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality.
    Núñez J; Bayés-Genís A; Zannad F; Rossignol P; Núñez E; Bodí V; Miñana G; Santas E; Chorro FJ; Mollar A; Carratalá A; Navarro J; Górriz JL; Lupón J; Husser O; Metra M; Sanchis J · Circulation · 2019
    Cohort study2,164 participantsHeart Health forPotassium
  10. Finerenone, Serum Potassium, and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction.
    Vardeny O; Vaduganathan M; Claggett BL; Desai AS; Jhund PS; Lam CSP; Senni M; Shah SJ; Voors AA; Zannad F; Pitt B; Matsumoto S; Merkely B; Zieroth S; Yilmaz MB; Lay-Flurrie J; Viswanathan P; Horvat-Broecker A; Scalise A; McMurray JJV; Solomon SD · JAMA cardiology · 2025
    Randomized trial6,001 participantsHeart Health forPotassium
  11. Quantitative Association Between Serum/Dietary Magnesium and Cardiovascular Disease/Coronary Heart Disease Risk: A Dose-Response Meta-analysis of Prospective Cohort Studies.
    Zhao L; Hu M; Yang L; Xu H; Song W; Qian Y; Zhao M · Journal of cardiovascular pharmacology · 2020
    Meta-analysis544,581 participants18 studies pooledHeart Health forMagnesium
  12. Effects of magnesium supplementation on improving hyperglycemia, hypercholesterolemia, and hypertension in type 2 diabetes: A pooled analysis of 24 randomized controlled trials.
    Xu L; Li X; Wang X; Xu M · Frontiers in nutrition · 2023
    Meta-analysis1,325 participants24 studies pooledHeart Health forMagnesium
  13. The effect of lowering blood pressure by magnesium supplementation in diabetic hypertensive adults with low serum magnesium levels: a randomized, double-blind, placebo-controlled clinical trial.
    Guerrero-Romero F; Rodríguez-Morán M · Journal of human hypertension · 2009
    Randomized trial82 participantsHeart Health forMagnesium
  14. Positive effects of magnesium supplementation in metabolic syndrome.
    Kisters S; Kisters K; Werner T; Vormann J; Tokmak F; Westhoff T; Gröber U; Predel HG; Reuter H · International journal of clinical pharmacology and therapeutics · 2024
    Randomized trial54 participantsHeart Health forMagnesium
  15. Comparative Efficacy of Nutraceuticals on Endothelial Function: A Systematic Review and Network Meta-Analysis.
    Norouzzadeh M; Rashedi MH; Mahdavi-Mazdeh G; Kosari A; Shahinfar H · Current atherosclerosis reports · 2026
    Meta-analysisHeart Health forMagnesium
  16. Joint association of urinary sodium and potassium excretion with cardiovascular events and mortality: prospective cohort study.
    O'Donnell M; Mente A; Rangarajan S; McQueen MJ; O'Leary N; Yin L; Liu X; Swaminathan S; Khatib R; Rosengren A; Ferguson J; Smyth A; Lopez-Jaramillo P; Diaz R; Avezum A; Lanas F; Ismail N; Yusoff K; Dans A; Iqbal R; Szuba A; Mohammadifard N; Oguz A; Yusufali AH; Alhabib KF; Kruger IM; Yusuf R; Chifamba J; Yeates K; Dagenais G; Wielgosz A; Lear SA; Teo K; Yusuf S; PURE Investigators · BMJ (Clinical research ed.) · 2019
    Cohort study103,570 participantsHeart Health forPotassium
  17. Effects of potassium supplementation on office, home, and 24-h blood pressure in patients with essential hypertension.
    Kawano Y; Minami J; Takishita S; Omae T · American journal of hypertension · 1999
    Randomized trial55 participantsHeart Health forPotassium